Dr. Robert Rohling

Dr. Robert Rohling

B.A.Sc. (Engineering Physics), UBC
M.Eng. (Biomedical Engineering), McGill University
Ph.D. (Information Engineering), University of Cambridge

Associate Members

Professor, Electrical and Computer Engineering & Mechanical Engineering (joint appointment), UBC


Robert Rohling received the B.A.Sc. degree in engineering physics from the University of British Columbia, the M.Eng. degree in biomedical engineering from McGill University, and the Ph.D. degree in information engineering from the University of Cambridge. He worked as the Project Manager of 3-D medical imaging at ALI Technologies, Vancouver, Canada, from 1999 to 2000, before joining the University of British Columbia, where he is now a Professor. He is the coordinator of the Biomedical Engineering option and Mechatronics option at UBC. He is also a member of DICOM on multidimensional interchange to set the standards for communicating medical images. His current research areas include adaptive ultrasound, 3-D ultrasound, elastography, and image-guided surgery.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


2016 Step Up team

Step Up Challenge fundraiser: February 25, 2018

The annual Step Up Challenge, raising funds for Prostate Cancer Canada, takes place in Vancouver on Sunday February 25. Click here to sponsor our relay team as they climbs 379 floors. Click here to volunteer to help with the event.

It's a Snow Day poster

It's A Snow Day at Mt. Seymour: March 9

Mt. Seymour is hosting It's A Snow Day, a fundraiser for Prostate Cancer Foundation BC, on Friday March 9. The event will include slope time, a reception, and a silent auction. Click here for more details including how to register, donate and/or sponsor.




Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.